• Je něco špatně v tomto záznamu ?

A Comparison of the Quality of Life of Patients With an Entirely Subcutaneous Implantable Defibrillator System Versus a Transvenous System (from the EFFORTLESS S-ICD Quality of Life Substudy)

SS. Pedersen, MH. Mastenbroek, N. Carter, C. Barr, P. Neuzil, M. Scholten, PD. Lambiase, L. Boersma, JB. Johansen, DA. Theuns,

. 2016 ; 118 (4) : 520-6. [pub] 20160528

Jazyk angličtina Země Spojené státy americké

Typ dokumentu srovnávací studie, časopisecké články, pozorovací studie

Perzistentní odkaz   https://www.medvik.cz/link/bmc17023880
E-zdroje Online Plný text

NLK ProQuest Central od 2012-08-15 do Před 2 měsíci
Nursing & Allied Health Database (ProQuest) od 2012-08-15 do Před 2 měsíci
Health & Medicine (ProQuest) od 2012-08-15 do Před 2 měsíci

Odkazy

PubMed 27353211
DOI 10.1016/j.amjcard.2016.05.047
Knihovny.cz E-zdroje

The first clinical results from the Evaluation of Factors Impacting Clinical Outcome and Cost Effectiveness of the subcutaneous implantable cardioverter defibrillator (EFFORTLESS S-ICD) Registry on the entirely S-ICD system are promising, but the impact of the S-ICD system on patients' quality of life (QoL) is not known. We evaluated the QoL of patients with an S-ICD against an unrelated cohort with a transvenous (TV)-ICD system during 6 months of follow-up. Consecutively implanted patients with an S-ICD system were matched with patients with a TV-ICD system on a priori selected variables including baseline QoL. QoL was measured with the Short-Form Health Survey at baseline, 3, and 6 months after implant and compared using multivariable modeling with repeated measures. Patients with an S-ICD (n = 167) versus a TV-ICD system (n = 167) did not differ significantly on physical (p = 0.8157) and mental QoL scores (p = 0.9080) across baseline, 3, and 6 months after implantation in adjusted analyses. The evolution in physical (p = 0.0503) and mental scores (p = 0.3772) during follow-up was similar for both cohorts, as indicated by the nonsignificant interaction effect for ICD system by time. Both patients with an S-ICD system and a TV-ICD system experienced significant improvements in physical and mental QoL between time of implant and 3 months (both p's <0.0001) and between time of implant and 6 months (both p's <0.0001) but not between 3 and 6 months (both p's >0.05). In conclusion, these first results show that the QoL of patients with an S-ICD versus TV-ICD system is similar and that patients with either system experience improvements in QoL on the short term.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17023880
003      
CZ-PrNML
005      
20170830102244.0
007      
ta
008      
170720s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.amjcard.2016.05.047 $2 doi
035    __
$a (PubMed)27353211
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Pedersen, Susanne S $u Department of Psychology, University of Southern Denmark, Odense, Denmark; Department of Cardiology, Odense University Hospital, Odense, Denmark; Department of Cardiology, Thorax Center, Erasmus Medical Center, Rotterdam, the Netherlands. Electronic address: sspedersen@health.sdu.dk.
245    12
$a A Comparison of the Quality of Life of Patients With an Entirely Subcutaneous Implantable Defibrillator System Versus a Transvenous System (from the EFFORTLESS S-ICD Quality of Life Substudy) / $c SS. Pedersen, MH. Mastenbroek, N. Carter, C. Barr, P. Neuzil, M. Scholten, PD. Lambiase, L. Boersma, JB. Johansen, DA. Theuns,
520    9_
$a The first clinical results from the Evaluation of Factors Impacting Clinical Outcome and Cost Effectiveness of the subcutaneous implantable cardioverter defibrillator (EFFORTLESS S-ICD) Registry on the entirely S-ICD system are promising, but the impact of the S-ICD system on patients' quality of life (QoL) is not known. We evaluated the QoL of patients with an S-ICD against an unrelated cohort with a transvenous (TV)-ICD system during 6 months of follow-up. Consecutively implanted patients with an S-ICD system were matched with patients with a TV-ICD system on a priori selected variables including baseline QoL. QoL was measured with the Short-Form Health Survey at baseline, 3, and 6 months after implant and compared using multivariable modeling with repeated measures. Patients with an S-ICD (n = 167) versus a TV-ICD system (n = 167) did not differ significantly on physical (p = 0.8157) and mental QoL scores (p = 0.9080) across baseline, 3, and 6 months after implantation in adjusted analyses. The evolution in physical (p = 0.0503) and mental scores (p = 0.3772) during follow-up was similar for both cohorts, as indicated by the nonsignificant interaction effect for ICD system by time. Both patients with an S-ICD system and a TV-ICD system experienced significant improvements in physical and mental QoL between time of implant and 3 months (both p's <0.0001) and between time of implant and 6 months (both p's <0.0001) but not between 3 and 6 months (both p's >0.05). In conclusion, these first results show that the QoL of patients with an S-ICD versus TV-ICD system is similar and that patients with either system experience improvements in QoL on the short term.
650    _2
$a činnosti denního života $7 D000203
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a náhlá srdeční smrt $x etiologie $x prevence a kontrola $7 D016757
650    12
$a defibrilátory implantabilní $7 D017147
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a multivariační analýza $7 D015999
650    _2
$a prospektivní studie $7 D011446
650    _2
$a implantace protézy $x metody $7 D019919
650    12
$a kvalita života $7 D011788
650    12
$a registrace $7 D012042
650    _2
$a komorová tachykardie $x komplikace $x terapie $7 D017180
650    _2
$a fibrilace komor $x komplikace $x terapie $7 D014693
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
655    _2
$a pozorovací studie $7 D064888
700    1_
$a Mastenbroek, Mirjam H $u Department of Cardiology, University Medical Center, Utrecht, the Netherlands.
700    1_
$a Carter, Nathan $u Boston Scientific Corporation, St Paul, Minnesota.
700    1_
$a Barr, Craig $u Cardiology Department, Russels Hall Hospital, Dudley, United Kingdom.
700    1_
$a Neuzil, Petr $u Department of Cardiology, Homnolka Hospital, Prague, Czech Republic.
700    1_
$a Scholten, Marcoen $u Department of Cardiology, Thorax Center Twente, Medisch Spectrum Twente, Enschede, the Netherlands.
700    1_
$a Lambiase, Pier D $u Cardiology Department, The Heart Hospital, Institute of Cardiovascular Science, University College London, London, United Kingdom.
700    1_
$a Boersma, Lucas $u Department of Cardiology, St. Antonius Ziekenhuis, Nieuwegein, the Netherlands.
700    1_
$a Johansen, Jens B $u Department of Cardiology, Odense University Hospital, Odense, Denmark.
700    1_
$a Theuns, Dominic A M J $u Department of Cardiology, Thorax Center, Erasmus Medical Center, Rotterdam, the Netherlands.
773    0_
$w MED00000236 $t The American journal of cardiology $x 1879-1913 $g Roč. 118, č. 4 (2016), s. 520-6
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27353211 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170720 $b ABA008
991    __
$a 20170830102832 $b ABA008
999    __
$a ok $b bmc $g 1239561 $s 984793
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 118 $c 4 $d 520-6 $e 20160528 $i 1879-1913 $m The American journal of cardiology $n Am J Cardiol $x MED00000236
LZP    __
$a Pubmed-20170720

Najít záznam

Citační ukazatele

Možnosti archivace